| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 19 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 18 |
| 2 | TACROLIMUS OINTMENT 0.1% | 18 |
| 3 | MYCOPHENILIC ACID | 11 |
| 4 | MYCOPHENOLIC ACID | 11 |
| 5 | RITUXIMAB | 10 |
| 6 | CYCLOSPORINE | 8 |
| 7 | MYCOPHENOLATE MOFETIL | 7 |
| 8 | PREDNISONE | 7 |
| 9 | SIROLIMUS | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MYCOPHENILIC ACID | 11 | 0.0005 |
| 1 | SIROLIMUS | 7 | 0.0005 |
| 2 | CEFOTAXIME INJECTION | 2 | 0.0005 |
| 3 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 4 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 5 | MYCOPHENOLIC ACID | 11 | 0.0003 |
| 6 | HUMAN IMMUNOGLOBULIN G | 4 | 0.0002 |
| 7 | GANCICLOVIR SODIUM | 2 | 0.0002 |
| 8 | EVEROLIMUS TABLETS | 3 | 0.0002 |
| 9 | TACROLIMUS OINTMENT 0.1% | 18 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 11 | 0.0005 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 8 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 10 | 0.0000 |
| 7 | Glycopeptide Antibacterial [EPC] | 2 | 0.0000 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 2 | 0.0000 |
| 9 | Kinase Inhibitor [EPC] | 10 | 0.0000 |